For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

The European Union's drugs regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the risk of serious brain ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

The latest drugs for Alzheimer's disease may add years of independence to the lives of patients, but possibly only for some.

Alzheimer’s disease doesn’t have a cure, meaning no treatment can reverse the damage that’s already occurred in the brain. But that doesn’t mean life has to come to a screeching halt.

Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

Alzheimer’s disease doesn’t have a cure, meaning no treatment can reverse the damage that’s already occurred in the brain. But that doesn’t mean life has to come to a screeching halt. There are ways ...

The most detailed brain metabolism simulation reveals new molecular targets for dementia treatment, offering hope to restore ...